Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
|更新时间:2024-10-09
|
Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
“The latest research found that Xuefu Zhuyu Capsule can improve dyslipidemia, aortic lipid deposition, increase ATP activity, increase the expression of Sirt3, and inhibit the expression of EPAC1 in atherosclerotic mice by regulating Sirt3/EPAC1 signal pathway, providing a new idea for the treatment of atherosclerosis.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 21, Pages: 31-41(2024)
YAO Bo,CHEN Hengwen,GONG Jiyu,et al.Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):31-41.
YAO Bo,CHEN Hengwen,GONG Jiyu,et al.Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(21):31-41. DOI: 10.13422/j.cnki.syfjx.20241622.
Xuefu Zhuyu Capsules Ameliorate Atherosclerosis in Mice by Regulating Sirt3/EPAC1 Signaling Pathway
Exploration in Relationship Between Mitochondrial Homeostasis Dysregulation and Panvascular Diseases Based on Theory of ''Positive Deficiency Phlegm Stasis''
Effect of Xuefu Zhuyu Capsules on Polarization of Macrophages in Mice with Atherosclerosis
Exploring Mechanism of Anti-atherosclerosis Effect of Huangqi Chifengtang Based on AMPK/PPARα Signaling Pathway and NLRP3 Inflammasome
Related Author
LI Hongping
WANG Jie
ZHANG Zhenpeng
LIU Chao
LIU Lanchun
HOU Chengzhi
LIU Menghua
ZHANG Dongmei
Related Institution
Dongzhimen Hospital,Beijing University of Chinese Medicine
Heilongjiang University of Chinese Medicine
Institute of Traditional Chinese Medicine,Heilongjiang University of Chinese Medicine